510(k) K260221
K260221 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys EBV EBNA IgG". The FDA issued a decision of Substantially Equivalent on Oct 2, 2026. The device falls under product code LSE (Epstein-Barr Virus, Other), a Class I device regulated under 21 CFR 866.3235. Roche Diagnostics has 456 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 2, 2026
- Date Received
- Jan 26, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Epstein-Barr Virus, Other
- Device Class
- Class I
- Regulation Number
- 866.3235
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.